Carbapenem Therapeutic Drug Monitoring in Critically Ill Adult Patients and Clinical Outcomes: A Systematic Review with Meta-Analysis.

Lechtig-Wasserman, Sharon; Liebisch-Rey, Hans; Diaz-Pinilla, Nicolas; Blanco, Jhosep; Fuentes-Barreiro, Yuli-Viviana; Bustos, Rosa-Helena

Lechtig-Wasserman, Sharon; Liebisch-Rey, Hans; Diaz-Pinilla, Nicolas; Blanco, Jhosep; Fuentes-Barreiro, Yuli-Viviana; Bustos, Rosa-Helena.

Afiliação

Lechtig-Wasserman S; Evidence-Based Therapeutics Group, Clinical Pharmacology, Universidad de La Sabana, Chía 140013, Colombia.
Liebisch-Rey H; Evidence-Based Therapeutics Group, Clinical Pharmacology, Universidad de La Sabana, Chía 140013, Colombia.
Diaz-Pinilla N; Evidence-Based Therapeutics Group, Clinical Pharmacology, Universidad de La Sabana, Chía 140013, Colombia.
Blanco J; Evidence-Based Therapeutics Group, Clinical Pharmacology, Universidad de La Sabana, Chía 140013, Colombia.
Fuentes-Barreiro YV; Evidence-Based Therapeutics Group, Clinical Pharmacology, Universidad de La Sabana, Chía 140013, Colombia.
Bustos RH; Evidence-Based Therapeutics Group, Clinical Pharmacology, Universidad de La Sabana, Chía 140013, Colombia.

Antibiotics (Basel) ; 10(2)2021 Feb 10.

Article em En | MEDLINE | ID: mdl-33578672

Palavras-chave

antibiotic treatment outcome; antimicrobial drug resistance; carbapenems; critical illness; gram-negative bacteria; sepsis; septic shock; therapeutic drug monitoring

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Antibiotics (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google